The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).
 
Alison Jane Birtle
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi
Speakers' Bureau - Bayer; Janssen Oncology; Pfizer
Research Funding - Genzyme
 
John David Chester
Honoraria - MSD
Travel, Accommodations, Expenses - MSD
 
Robert J. Jones
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EUSA Pharma; Ipsen; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Pharmacyclics; Roche/Genentech; Sanofi; Seagen
Consulting or Advisory Role - Clovis Oncology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; MSD
 
Ben Jenkins
No Relationships to Disclose
 
Mark Johnson
Research Funding - Astellas Pharma (Inst)
 
James WF Catto
Honoraria - Abbott Laboratories
Consulting or Advisory Role - AstraZeneca/MedImmune; Ferring; Janssen
Speakers' Bureau - ASCO; AstraZeneca/MedImmune; MSD Oncology; Nucleix; Roche
Travel, Accommodations, Expenses - European Association of Urology
 
Thomas Powles
Honoraria - AstraZeneca; Bristol-Myers Squibb; Exelixis; Incyte; Ipsen; MSD; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
 
Richard T. Bryan
Research Funding - QED Therapeutics (Inst); UroGen pharma (Inst)
Patents, Royalties, Other Intellectual Property - Cambridge Mechatronics Limited (Inst); University of Oxford (Inst)
Travel, Accommodations, Expenses - Janssen
 
Anthony Blacker
Stock and Other Ownership Interests - Coventry Urology; Diagnostics UK
 
Prabir R Chakraborti
No Relationships to Disclose
 
Satinder Jagdev
Honoraria - Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Ipsen
 
John Wagstaff
No Relationships to Disclose
 
Anna Tolentino
No Relationships to Disclose
 
Luke Webster
No Relationships to Disclose
 
Rebecca Lewis
No Relationships to Disclose
 
Emma Hall
Research Funding - Accuray (Inst); Alliance Pharma (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer (Inst); Kyowa Hakko UK (Inst); Merck Sharpe & Dohme (Inst); Varian Medical Systems (Inst)